<PAGE>
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________________________
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report: March 31, 2000
-------------------------------
(Date of earliest event reported)
BAXTER INTERNATIONAL INC.
-------------------------
(Exact name of registrant as specified in its charter)
Delaware
--------
(State or other jurisdiction of incorporation)
1-4448 36-0781620
- ------------------------- ---------------------------------
(Commission file number) (IRS Employer Identification No.)
One Baxter Parkway, Deerfield, Illinois 60015
- --------------------------------------- -----
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (847) 948-2000
- --------------------------------------------------------------------------------
(Page 1 of 3 pages)
<PAGE>
Item 2. Acquisition or Disposition of Assets
On March 31, 2000, Baxter International Inc. ("Baxter") completed the
distribution of Edwards Lifesciences Corporation common stock to shareholders of
record of Baxter common stock on March 29, 2000. Edwards Lifesciences
Corporation was formed initially as a wholly owned subsidiary of Baxter and is
primarily comprised of the cardiovascular business previously conducted by
Baxter.
(Page 2 of 3 pages)
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
BAXTER INTERNATIONAL INC.
(Registrant)
By: /s/ Jan Stern Reed
-------------------
Jan Stern Reed
Secretary
Date: April 14, 2000
(Page 3 of 3 pages)
